Additional file 5: of The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

Table S3. SLC7A5 mRNA and patient outcome. (DOCX 14 kb)